Zalups R K, Barfuss D W
Division of Basic Medical Sciences, Mercer University School of Medicine, Macon, GA 31207, USA.
Toxicology. 1995 Nov 20;103(1):23-35. doi: 10.1016/0300-483x(95)03099-2.
The effects of intravenous pretreatment with the organic anion p-aminohippurate (PAH) on the disposition of intravenously administered inorganic mercury in the kidneys, liver and blood were evaluated in rats. In dose-response experiments, the renal uptake (and/or accumulation) of mercury, 1 h after the injection of a nontoxic 0.5 mumol/kg dose of mercuric chloride (HgCl2), was significantly reduced in rats when a 1.0, 3.3 or 10 mmol/kg dose of PAH was administered 5 min prior to the injection of HgCl2. This reduction was due to reduced uptake of mercury in both the renal cortex and outer stripe of the outer medulla. Near maximal inhibition appeared to be achieved with the 10 mmol/kg dose of PAH. Inhibition of the uptake (an/or accumulation) of mercury in the renal cortex and outer stripe of the outer medulla, 1 h after the injection of the nontoxic dose of HgCl2, was also detected in experiments where HgCl2 was injected 5, 30, 60 or 180 min after pretreatment with a 10 mmol/kg dose of PAH. The renal uptake of mercury was inhibited significantly when the nontoxic dose of inorganic mercury was administered 5, 30, or 60, but not 180 min after pretreatment with the 10 mmol/kg dose of PAH. In another experiment, the renal burden of mercury was significantly reduced for 24 h when pretreatment with a 10 mmol/kg dose of PAH was administered 5 min prior to the injection of HgCl2. Pretreatment with PAH did not have an effect on the hepatic disposition of mercury, but it did cause a significant increase in the fraction of mercury present in the plasma of blood. In summary, the findings in the present study indicate that pretreatment with PAH inhibits the renal uptake of injected inorganic mercury in a dose-dependent and time-dependent manner. In addition, the findings tend to indicate that some fraction of the mercury that enters into renal tubular epithelial cells is by a mechanism involving the organic anion transport system.
在大鼠中评估了用有机阴离子对氨基马尿酸(PAH)进行静脉预处理对静脉注射的无机汞在肾脏、肝脏和血液中的处置情况的影响。在剂量反应实验中,当在注射氯化汞(HgCl2)前5分钟给予1.0、3.3或10 mmol/kg剂量的PAH时,注射无毒剂量0.5 μmol/kg的HgCl2 1小时后,大鼠肾脏对汞的摄取(和/或蓄积)显著降低。这种降低是由于肾皮质和外髓质外层汞摄取减少所致。10 mmol/kg剂量的PAH似乎能达到近乎最大程度的抑制。在给予10 mmol/kg剂量的PAH预处理后5、30、60或180分钟注射HgCl2的实验中,也检测到在注射无毒剂量的HgCl2后一小时,肾皮质和外髓质外层汞的摄取(和/或蓄积)受到抑制。当在给予10 mmol/kg剂量的PAH预处理后5、30或60分钟而非180分钟给予无毒剂量的无机汞时,肾脏对汞的摄取受到显著抑制。在另一项实验中,当在注射HgCl2前5分钟给予10 mmol/kg剂量的PAH预处理时,汞的肾脏负荷在24小时内显著降低。PAH预处理对汞在肝脏中的处置没有影响,但确实导致血液中血浆汞的比例显著增加。总之,本研究结果表明,PAH预处理以剂量依赖性和时间依赖性方式抑制注射的无机汞的肾脏摄取。此外,这些结果倾向于表明,进入肾小管上皮细胞的部分汞是通过涉及有机阴离子转运系统的机制进行的。